V60L (p.Val60Leu) variant of CASQ2 (Calsequestrin-2)

V60L (p.Val60Leu) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data and structural context.

V60L (p.Val60Leu) variant details